Omicron News and Research

RSS

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Researchers conducted a retrospective analysis to evaluate the duration of the SARS-CoV-2 Omicron variant virus shedding

18 Mar 2022

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

Researchers reported an epitope with high potency and breadth and demonstrated that a therapeutic antibody directed at this site neutralizes all SARS-CoV-2 variants.

18 Mar 2022

COVID-19-related hospitalization among infants and young children in the US

Researchers investigated COVID-19-associated hospitalization among children and infants aged zero to four years in the United States during March 2020 and February 2022.

18 Mar 2022

Researchers argue that Omicron's lower severity is a coincidence

Researchers raised concern regarding the emergence of new SARS-CoV-2 variants with unpredictable severity and immune evasion potential due to its ongoing fast-paced antigenic evolution.

18 Mar 2022

New PCR test uses molecular beacons to identify the specific variant causing COVID-19 infection

After the start of the SARS-C0V-2 pandemic, investigators from ResearchPath LLC and their collaborators at Rutgers University quickly dedicated resources to develop accurate and reliable COVID-19 testing.

17 Mar 2022

Breakthrough infection could provide broad protection against current SARS-CoV-2 variants of concern

A delta breakthrough infection generates a potent and broad neutralizing antibody response in double vaccinated individuals, according to new research.

17 Mar 2022

Why does the SARS-CoV-2 Omicron variant escape immunity?

Researchers reveal the underlying mechanism associated with the Omicron variant’s increased transmissibility and ability to evade immunity.

17 Mar 2022

Immuno-metabolomic signatures that correlate with antigen-specific-T cell response during active COVID-19

Researchers investigate innate and adaptive immune responses at both the early and late stages of SARS-CoV-2 infection.

17 Mar 2022

Impact of new COVID vaccinations as novel variants emerge

Researchers explores the changing value of COVID-19 vaccines in a scenario of dynamic immunity and rapidly evolving variants of concern.

17 Mar 2022

Single dose of Pfizer vaccine reduces risk of SARS-CoV-2 infection in kids

Researchers discuss the efficacy of COVID-19 vaccines in young people and children when the SARS-CoV-2 Delta- and Omicron-dominant periods.

17 Mar 2022

Novel screening method detects new N501T SARS-CoV-2 variant

Researchers develop two SARS-CoV-2 Mutation Discrimination assays that have been designed to detect 501 and 484 mutations on the spike protein.

17 Mar 2022

Study finds out-of-pocket spending for health care after COVID-19 hospital stay

Millions of Americans have needed hospitalization for COVID-19 since the pandemic began, including hundreds of thousands in the recent Omicron surge.

17 Mar 2022

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

As immunocompromised people across the country work to get Evusheld, a potentially lifesaving covid therapy, several hundred providers of the injections were removed from a federal dataset on Wednesday night, making the therapy even harder to locate.

17 Mar 2022

Omicron SARS-CoV-2 variant is more stable than its ancestral strain on smooth and porous surfaces

Researchers showed that the SARS-CoV-2 Omicron variant of concern is more stable on smooth and porous surfaces compared to its five ancestral strains.

17 Mar 2022

Study finds co-infected individuals carrying two distinct lineages of SARS-CoV-2 in Argentina

Researchers used molecular surveillance to identify cases of co-infection with SARS-CoV-2 variants of concern Delta and Omicron reported in Argentina during December 2021 and January 2022.

17 Mar 2022

MHRA authorizes new medicine for COVID-19 prevention

A new medicine, Evusheld (tixagevimab/cilgavimab), has today been authorised for COVID-19 prevention by the Medicines and Healthcare products Regulatory Agency (MHRA) after meeting the UK regulatory standards of safety, quality and effectiveness.

17 Mar 2022

Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

Researchers used a novel mathematical model to simulate SARS-CoV-2 dynamics inside the host.

17 Mar 2022

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

Researchers constructed a novel fusion inhibitor−based recombinant protein, referred to as 5−Helix, to block SARS-CoV-2 spike-mediated cell-cell fusion.

17 Mar 2022

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

Researchers compared the efficacy of booster doses of heterologous intramuscular and aerosolized adenovirus-vectored vaccine, a recombinant protein-based ZF2001 vaccine, and homologous CoronaVac vaccines.

17 Mar 2022

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

Researchers assessed the safety profile and immunogenicity of a heterologous NVSI-06-08 boost against SARS-CoV-2 variants in individuals doubly vaccinated with the inactivated vaccine BBIBP-CorV.

17 Mar 2022

Omicron News and Research

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

COVID-19-related hospitalization among infants and young children in the US

Researchers argue that Omicron's lower severity is a coincidence

New PCR test uses molecular beacons to identify the specific variant causing COVID-19 infection

Breakthrough infection could provide broad protection against current SARS-CoV-2 variants of concern

Why does the SARS-CoV-2 Omicron variant escape immunity?

Immuno-metabolomic signatures that correlate with antigen-specific-T cell response during active COVID-19

Impact of new COVID vaccinations as novel variants emerge

Single dose of Pfizer vaccine reduces risk of SARS-CoV-2 infection in kids

Novel screening method detects new N501T SARS-CoV-2 variant

Study finds out-of-pocket spending for health care after COVID-19 hospital stay

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

Omicron SARS-CoV-2 variant is more stable than its ancestral strain on smooth and porous surfaces

Study finds co-infected individuals carrying two distinct lineages of SARS-CoV-2 in Argentina

MHRA authorizes new medicine for COVID-19 prevention

Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News